Lam, Marnix
Garin, Etienne
Palard-Novello, Xavier
Mahvash, Armeen
Kappadath, Cheenu
Haste, Paul
Tann, Mark
Herrmann, Ken
Barbato, Francesco
Geller, Brian
Schaefer, Niklaus
Denys, Alban
Dreher, Matthew
Fowers, Kirk D.
Gates, Vanessa
Salem, Riad
Funding for this research was provided by:
BTG
Boston Scientific Corporation
Article History
Received: 7 June 2023
Accepted: 24 August 2023
First Online: 12 September 2023
Declarations
:
: Not applicable.
: Not applicable.
: Marnix Lam, MD, PhD, is a consultant for Boston Scientific, Terumo, and Quirem Medical. He receives research support from Boston Scientific, Terumo, and Quirem Medical. The UMC Utrecht receives royalties from Quirem Medical.Etienne Garin, MD, PhD, serves as a consultant for Boston Scientific.Xavier Palard-Novello, MD, PhD: none.Armeen Mahvash, MD, is a consultant for Boston Scientific, Sirtex Medical, and ABK Biomedical. He received research support from Boston Scientific, Sirtex Medical, ABK Biomedical, and Siemens Healthineers.Cheenu Kappadath, PhD, is a consultant for Boston Scientific, Sirtex Medical, and Terumo Medical. He receives research support from Boston Scientific, Sirtex Medical, and Terumo Medical.Paul Haste, MD, is a consultant for Boston Scientific.Mark Tann, MD: none.Ken Herrmann, MD, reports personal fees from Bayer, personal fees and others from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, personal fees from Aktis Oncology, personal fees from Theragnostics, personal fees from Pharma15, and outside the submitted work.Francesco Barbato, MD: none.Brian Geller, MD, is a consultant for Boston Scientific.Niklaus Schaefer, MD: none.Alban Denys, MD, MSc, is a consultant for Cook, Neuwave, and received grand from Johnson and Johnson.Matthew R. Dreher, PhD, works for Boston Scientific.Kirk D. Fowers, PhD, works for Boston Scientific.Riad Salem, MD, is a consultant for Boston Scientific, Astrazeneca, Genentech, Sirtex, Cook, Eisai, Bard, and QED Therapeutics.Vanessa L. Gates, MS, is a consultant for Boston Scientific.